Semus Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $455K | Buy |
2,450
+23
| +0.9% | +$4.27K | 0.29% | 63 |
|
|
2025
Q1 | $508K | Buy |
2,427
+35
| +1% | +$7.33K | 0.35% | 51 |
|
|
2024
Q4 | $425K | Sell |
2,392
-41
| -2% | -$7.29K | 0.28% | 63 |
|
|
2024
Q3 | $480K | Buy |
2,433
+27
| +1% | +$5.33K | 0.34% | 57 |
|
|
2024
Q2 | $413K | Buy |
2,406
+231
| +11% | +$39.6K | 0.32% | 60 |
|
|
2024
Q1 | $396K | Sell |
2,175
-1
| -0% | -$182 | 0.33% | 72 |
|
|
2023
Q4 | $337K | Buy |
2,176
+23
| +1% | +$3.56K | 0.28% | 79 |
|
|
2023
Q3 | $321K | Buy |
2,153
+17
| +0.8% | +$2.53K | 0.3% | 77 |
|
|
2023
Q2 | $288K | Sell |
2,136
-38
| -2% | -$5.12K | 0.26% | 86 |
|
|
2023
Q1 | $346K | Sell |
2,174
-212
| -9% | -$33.8K | 0.37% | 65 |
|
|
2022
Q4 | $386K | Buy |
+2,386
| New | +$386K | 0.47% | 59 |
|